Assessing the efficacy of darolutamide in metastatic hormone-sensitive prostate cancer based on subgroup meta-analysis and reconstructed individual patient data.

ABSTRACT:

SUBMITTER: Zhang F 

PROVIDER: S-EPMC12589698 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature